Click here to read the full article
A peer-reviewed study measuring the effectiveness of a controversial drug cocktail that includes hydroxychloroquine concluded that the treatment lowered hospitalizations and mortality rates of coronavirus patients.
The study, set to be published in the International Journal of Antimicrobial Agents in December, determined that “Low-dose hydroxychloroquine combined with zinc and azithromycin was an effective therapeutic approach against COVID-19.”
A total of 141 patients diagnosed with the coronavirus were treated with the three-drug cocktail over a period of five days and compared to a control group of 377 people who tested positive for the virus but were not given the treatment.